Table 1.
Patient and tumour characteristics
| Age in years | |
| Median (range) | 64 (45–78) |
| Gender: % (n) | |
| Male | 69% (11) |
| Female | 31% (5) |
| Explored before neoadjuvant chemoradiation: % (n) | |
| Yes | 31% (5) |
| No | 69% (11) |
| Location of the tumour: % (n) | |
| Head | 69% (11) |
| Body | 18% (3) |
| Tail | 13% (2) |
| Tumour size (mean ± SD) | |
| Pre-treatment | 3.85 ± 1.92NS (P = 0.1423) |
| Post-treatment | 3.39 ± 1.81 |
| Tumour extension at presentation: % (n) | |
| Borderline resectable | 62.5% (10) |
| Locally advanced | 37.5% (6) |
| CA 19-9 levels: | |
| Pre-treatment | 1436 ± 772NS (P = 0.12) |
| Post-treatment | 772 ± 220 |
| Tumour density in Hounsfield units | |
| Pre-treatment | 60.4 ± 6.5NS (P = 0.3698) |
| Post-treatment | 58.2 ± 6.9 |
| Radiological response: % (n) | |
| Regression | 0% (0) |
| Stable | 69% (11) |
| Progression | 31% (5) |
| Surgical resection of cancer after neo-adjuvant chemoradiation: % (n) | |
| Yes | 31% (5) |
| No | 69% (11) |
| Patients undergoing surgical resection classified by tumour extension at presentation: % (n) | |
| Borderline resectable | 50% (5) |
| Locally advanced | 0% (0) |
| Pathological response in those undergoing a resection (n = 5) | |
| Macroscopic tumour | 4 |
| Microscopic tumour only | 1 |
NS, non-significant.